Cancer Highlights is a publication series covering key topics in the field of oncology. It focuses on R&D and business development. Cancer Highlights has 14 publications in total, covering three main topics updated over an 18 months cycle. 
Each publication is written by BioSeeker's oncology professionals who have years of experience analyzing cancer R&D and business development.
BioSeeker's knowledge base in oncology includes more than 1,000 cancer R&D companies and close to 3,000 drugs, from drug discovery to marketed. Cancer Highlights is designed by BioSeeker to assist and enhance our readers' business insights and intelligence in oncology. These reports will assist to: - improved competitor analysis
- outline R&D alignments
- identify and follow trends and future insights
- identify key breakthroughs important for your company
- track cutting edge companies, therapies and new technologies
- save significant time in identifying your partners & competitors
Pricing ModelOur pricing model for Cancer Highlights is very competitive and is a worthy investment for any company, from small biotechs to big pharma. Read more about our licenses below. 
*One subscription cycle (Approx. 1 year) includes 8 consecutive publications.
Back issues of any Cancer Highlights publication is available at only 780 EUR (PDF) for subscribers. To Subscribe To start a one year subscription choose Quantity 1 for single user license, Quantity 2 for site license and Quantity 3 for global license below. Do not forget to press update after your selection of quantity. You may select your first Cancer Highlights report by leaving us a note to with your order. Default is the most present Cancer Highlights published. One year subscription includes 8 consecutive publications. Your subscription will end after 8 publications and you have the option make a renewal.
|
